These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

869 related items for PubMed ID: 26108266

  • 1. Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.
    Medina-Gil C, Dehesa L, Vega A, Kerdel F.
    Int J Dermatol; 2015 Jul; 54(7):846-52. PubMed ID: 26108266
    [Abstract] [Full Text] [Related]

  • 2. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK, Rafiq A, Östör AJ.
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [Abstract] [Full Text] [Related]

  • 3. Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.
    Sánchez-Moya AI, Dauden E.
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):730-3. PubMed ID: 21564322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
    Tsai TF, Ho V, Song M, Szapary P, Kato T, Wasfi Y, Li S, Shen YK, Leonardi C, PHOENIX 1, PHOENIX 2, ACCEPT, PEARL and Japanese Ustekinumab Study Groups.
    Br J Dermatol; 2012 Nov; 167(5):1145-52. PubMed ID: 22803615
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.
    Li CR, Mao QX, Chen M, Jia WX, Yao X, Feng SY, Jia H, Gong JQ, Yang XY.
    Drug Des Devel Ther; 2015 Nov; 9():5591-4. PubMed ID: 26508833
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Ramos GP, Stroh G, Al-Bawardy B, Faubion WA, Papadakis KA, Escalante P.
    Inflamm Bowel Dis; 2018 Sep 15; 24(10):2272-2277. PubMed ID: 29718223
    [Abstract] [Full Text] [Related]

  • 13. Latent tuberculosis infection screening prior to biological treatment in Tunisian patients.
    Slouma M, Mahmoud I, Saidane O, Bouden S, Abdelmoula L.
    Therapie; 2017 Oct 15; 72(5):573-578. PubMed ID: 28318613
    [Abstract] [Full Text] [Related]

  • 14. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis.
    Amerio P, Amoruso G, Bardazzi F, Campanati A, Cassano N, Conti A, Gisondi P, Guarneri C, Mazzotta A, Piaserico S, Prestinari F, Prignano F, Zane C, de Simone C.
    J Dermatolog Treat; 2013 Aug 15; 24(4):305-11. PubMed ID: 22208431
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease.
    Taxonera C, Ponferrada Á, Riestra S, Bermejo F, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Rivero M, Fernandez-Salazar L, Nantes Ó, Merino O, Alba C, Gisbert JP, CONVERT study group from GETECCU .
    J Crohns Colitis; 2018 Nov 15; 12(11):1270-1279. PubMed ID: 30052856
    [Abstract] [Full Text] [Related]

  • 18. Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.
    Baniandrés O, Rodríguez-Soria VJ, Romero-Jiménez RM, Suárez R.
    Actas Dermosifiliogr; 2015 Sep 15; 106(7):569-77. PubMed ID: 25935194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Screening of health-care workers for latent tuberculosis infection in a Tertiary Care Hospital.
    Janagond AB, Ganesan V, Vijay Kumar GS, Ramesh A, Anand P, Mariappan M.
    Int J Mycobacteriol; 2017 Sep 15; 6(3):253-257. PubMed ID: 28776523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.